The safety and effectiveness of early anti-platelet therapy after alteplase for acute ischemic stroke: A meta-analysis

被引:12
作者
Liu, Jiangyun [1 ,2 ]
Hu, Xingxing [1 ,2 ]
Wang, Yu [1 ,2 ]
Guan, Xueneng [1 ,2 ]
Chen, Jiao [1 ,2 ]
Liu, Hongquan [1 ,2 ]
机构
[1] Nanjing Univ Chinese Med, Affiliated Hosp Integrated Tradit Chinese & Weste, Nanjing, Peoples R China
[2] Jiangsu Prov Acad Tradit Chinese Med, Nanjing, Peoples R China
关键词
Early anti-platelet therapy; Alteplase; Ischemic stroke; Safety; Effectiveness; Meta-analysis; TISSUE-PLASMINOGEN ACTIVATOR; LYSIS UTILIZING EPTIFIBATIDE; MIDDLE CEREBRAL-ARTERY; RECANALIZATION; THROMBOLYSIS; OUTCOMES; ASPIRIN; PA;
D O I
10.1016/j.jocn.2021.07.002
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: For acute ischemic stroke patients, there is a risk of reocclusion after intravenous thrombol-ysis. In theory, early anti-platelet therapy can reduce the risk of vessel reocclusion. Although current guidelines do not recommend routine anti-platelet therapy within 24 h of intravenous thrombolytic ther-apy, many studies disagreed with it, especially after the emergence of new anti-platelet drugs. It is nec-essary to conduct a meta-analysis based on high-quality randomized controlled studies to re-evaluate this treatment strategy. Methods: Literature retrieval was systematically conducted in PubMed, Embase, Cochrane, Web of sicence, clinical trials, CNKI and Wanfang Data, for searching randomized controlled trials (published between January 1, 2000 and April 30, 2020 with no language restrictions) comparing early (within 24 h) with routine (after 24 h) anti-platelet-aggregation therapy after rt-PA intravenous thrombolysis. The primary safety endpoint and primary efficacy indicator are the incidence of symptomatic intracranial hemorrhage and a good prognosis at 90-day (modified Rankin Scale (mRS) score of 0-1 or return to base-line mRS), respectively. We assessed pooled data by use of a random-effects model. Findings: Of the 378 identified studies, only 3 were eligible and included in our analysis (N = 1008 par-ticipants). Compared with routine treatment, early anti-platelet-aggregation therapy after rt-PA intra-venous thrombolysis in acute ischemic stroke patients did not affect the 90-day efficacy (95% CI 0.97 - 1.32). In terms of safety assessment, the early use of anti-platelet-aggregation drugs after thrombolysis has a neutral effect on the risk of intracranial hemorrhage, symptomatic intracranial hemorrhage, and bleeding from other systemic sites. Conclusion: Early anti-platelet therapy after alteplase did not benefit the acute ischemic stroke patients based on the current evidence. However, more clinical trials and statistical evidence are still needed. (c) 2021 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:176 / 182
页数:7
相关论文
共 50 条
[31]   Impact of diabetes on clinical and safety outcomes in acute ischemic stroke patients receiving reperfusion therapy: A meta-analysis [J].
Bradley, Sian Alexandra ;
Smokovski, Ivica ;
Bhaskar, Sonu Menachem Maimonides .
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 31 (06) :583-596
[32]   Tenecteplase versus alteplase for the treatment of acute ischemic stroke: a meta-analysis of randomized controlled trials [J].
Huang, Jian ;
Zheng, Hui ;
Zhu, Xianfeng ;
Zhang, Kai ;
Ping, Xiaofeng .
ANNALS OF MEDICINE, 2024, 56 (01)
[33]   Tenecteplase versus alteplase for patients with acute ischemic stroke: a meta-analysis of randomized controlled trials [J].
Zhang, Xu ;
Wan, Teng-Fei ;
Chen, Jing ;
Liu, Liang .
AGING-US, 2023, 15 (24)
[34]   Efficacy and safety outcomes of Tenecteplase versus Alteplase for thrombolysis of acute ischemic stroke: A meta-analysis of 9 randomized controlled trials [J].
Wang, Yue ;
Cai, Xiuying ;
Fang, Qi ;
Zhu, Juehua .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 458
[35]   Ethnic Differences in the Safety and Efficacy of Tenecteplase Versus Alteplase for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis [J].
Koh, Jin Hean ;
Lim, Claire Yi Jia ;
Tan, Lucas Tze Peng ;
Sia, Ching-Hui ;
Poh, Kian Keong ;
Sharma, Vijay Kumar ;
Yeo, Leonard Leong Litt ;
Ho, Andrew Fu Wah ;
Wu, Teddy ;
Kong, William Kok-Fai ;
Tan, Benjamin Yong Qiang .
JOURNAL OF STROKE, 2024, 26 (03) :371-390
[36]   Efficacy and safety of intravenous tenecteplase compared to alteplase before mechanical thrombectomy in acute ischemic stroke: a meta-analysis [J].
Wu, Nihong ;
Doeppner, Thorsten R. ;
Hermann, Dirk M. ;
Gronewold, Janine .
JOURNAL OF NEUROLOGY, 2024, 271 (07) :3928-3941
[37]   Albumin therapy for acute ischemic stroke: a meta-analysis [J].
Yanjie Huang ;
Zheng Xiao .
Neurological Sciences, 2021, 42 :2713-2719
[38]   Effect of antiplatelet pretreatment on safety and efficacy outcomes in acute ischemic stroke patients after intravenous thrombolysis: a systematic review and meta-analysis [J].
Sun, Chao ;
Song, Baili ;
Jiang, Chunlian ;
Zou, Jian-Jun .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (04) :349-358
[39]   Safety and efficacy of early antiplatelet therapy in acute ischemic stroke patients receiving endovascular treatment: A systematic review and meta-analysis [J].
Guo, Yijia ;
Lin, Yapeng ;
Tang, Yifang ;
Tang, Qin ;
Wang, Xiaoqing ;
Pan, Xiding ;
Zou, JianJun ;
Yang, Jie .
JOURNAL OF CLINICAL NEUROSCIENCE, 2019, 66 :45-50
[40]   Safety and efficacy of intravenous thrombolysis in patients with acute ischemic stroke taking direct oral anticoagulants prior to stroke: a meta-analysis [J].
Liang, Huo ;
Wang, Xue ;
Quan, Xuemei ;
Qin, Bin ;
Zhang, Jian ;
Liang, Shuolin ;
Liang, Zhijian .
JOURNAL OF NEUROLOGY, 2023, 270 (09) :4192-4200